miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer

Hong Tan1, Qingnan He2, Guanhui Gong3

  • 1Department of Pathology, School of Basic Medical Science, Central South University, Changsha, Hunan 410013, P.R. China.

Insights

MicroRNA-382 (miR-382) is downregulated in ovarian cancer, inhibiting cell proliferation and metastasis. It targets ROR1, suppressing migration and invasion by regulating epithelial-mesenchymal transition (EMT).

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are crucial in cancer development.
  • Reduced miR-382 expression is noted in several cancers.
  • The role of miR-382 in ovarian cancer remains unclear.

Purpose of the Study:

  • To investigate the function of miR-382 in ovarian cancer.
  • To identify the molecular targets of miR-382 in this context.

Main Methods:

  • Analysis of miR-382 expression in ovarian cancer tissues and cell lines.
  • Assessment of miR-382's effects on ovarian cancer cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT).
  • Identification and validation of ROR1 as a direct target of miR-382.

Main Results:

  • miR-382 expression was significantly downregulated in human ovarian cancer tissues and cell lines.
  • Overexpression of miR-382 suppressed ovarian cancer cell proliferation, migration, invasion, and EMT.
  • Receptor tyrosine kinase orphan receptor 1 (ROR1) was identified as a direct target of miR-382.
  • miR-382 counteracted ROR1's pro-migratory, pro-invasive, and EMT-promoting effects.

Conclusions:

  • miR-382 functions as a tumor suppressor in ovarian cancer.
  • miR-382 inhibits ovarian cancer cell migration and invasion by targeting ROR1 and regulating EMT.
  • miR-382 represents a potential therapeutic target for ovarian cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K